Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppression.

Abstract:

:Sex-determining region Y box 6 (SOX6) has been described as a tumor-suppressor gene in several cancers. Our previous work has suggested that SOX6 upregulated p21(Waf1/Cip1)(p21) expression in a p53-dependent manner; however, the underlying mechanism has remained elusive. In this study, we confirmed that SOX6 can suppress cell proliferation in vitro and in vivo by stabilizing p53 protein and subsequently upregulating p21. Co-immunoprecipitation and immunocytofluorescence assays demonstrated that SOX6 can promote formation of the p14ARF-HDM2-p53 ternary complex by promoting translocation of p14ARF (p14 alternate reading frame tumor suppressor) to the nucleoplasm, thereby inhibiting HDM2-mediated p53 nuclear export and degradation. Chromatin immunoprecipitation combined with PCR assay proved that SOX6 can bind to a potential binding site in the regulatory region of the c-Myc gene. Furthermore, we confirmed that SOX6 can downregulate the expression of c-Myc, as well as its direct target gene nucleophosmin 1 (NPM1), and that the SOX6-induced downregulation of NPM1 is linked to translocation of p14ARF to the nucleoplasm. Finally, we showed that the highly conserved high-mobility group (HMG) domain of SOX6 is required for SOX6-mediated p53 stabilization and tumor inhibitory activity. Collectively, these results reveal a new mechanism of SOX6-mediated tumor suppression involving p21 upregulation via the p14ARF-HDM2-p53 axis in an HMG domain-dependent manner.

journal_name

Oncogene

journal_title

Oncogene

authors

Wang J,Ding S,Duan Z,Xie Q,Zhang T,Zhang X,Wang Y,Chen X,Zhuang H,Lu F

doi

10.1038/onc.2015.234

subject

Has Abstract

pub_date

2016-03-31 00:00:00

pages

1692-702

issue

13

eissn

0950-9232

issn

1476-5594

pii

onc2015234

journal_volume

35

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Drosophila asymmetric division, polarity and cancer.

    abstract::A limited number of adult stem cells (SCs) maintain the homoestasis of different tissues through the lifetime of the individual by generating differentiating daughters and renewing themselves. Errors in the SC division rate or in the fine balance between self-renewal and differentiation might result in tissue overgrow...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2008.349

    authors: Januschke J,Gonzalez C

    更新日期:2008-11-24 00:00:00

  • Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression.

    abstract::Abundant data support a key role for the transcription factor nuclear factor-kappaB (NF-kappaB) signaling pathway in controlling the initiation and progression of human cancer. NF-kappaB and associated regulatory proteins such as IkappaB kinase (IKK) are activated downstream of many oncoproteins and there is much evid...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1209942

    authors: Bassères DS,Baldwin AS

    更新日期:2006-10-30 00:00:00

  • Nerve growth factor induces survival and differentiation through two distinct signaling cascades in PC12 cells.

    abstract::Nerve growth factor induces differentiation and survival of rat PC12 pheochromocytoma cells. The activation of the erk cascade has been implicated in transducing the multitude of signals induced by NGF. In order to explore the role of this signaling cascade in NGF mediated survival, differentiation and proliferation, ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202524

    authors: Klesse LJ,Meyers KA,Marshall CJ,Parada LF

    更新日期:1999-03-25 00:00:00

  • EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer.

    abstract::EDD (E3 isolated by differential display), located at chromosome 8q22.3, is the human orthologue of the Drosophila melanogaster tumour suppressor gene 'hyperplastic discs' and encodes a HECT domain E3 ubiquitin protein-ligase. To investigate the possible involvement of EDD in human cancer, several cancers from diverse...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206775

    authors: Clancy JL,Henderson MJ,Russell AJ,Anderson DW,Bova RJ,Campbell IG,Choong DY,Macdonald GA,Mann GJ,Nolan T,Brady G,Olopade OI,Woollatt E,Davies MJ,Segara D,Hacker NF,Henshall SM,Sutherland RL,Watts CK

    更新日期:2003-08-07 00:00:00

  • Regulation of TRAIL-induced apoptosis by XIAP in pancreatic carcinoma cells.

    abstract::Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a promising candidate for cancer therapy because of its relative tumor selectivity. However, many cancers including pancreatic cancer remain resistant towards TRAIL. To develop TRAIL for cancer therapy of pancreatic carcinoma, it will therefore b...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209776

    authors: Vogler M,Dürr K,Jovanovic M,Debatin KM,Fulda S

    更新日期:2007-01-11 00:00:00

  • Induction of a complex between rasGAP and a novel 110 kD protein is required for immortalization of primary epithelial cells by the E1A 12S oncoprotein of adenovirus.

    abstract::Although established cell lines can be transformed with oncogenic ras, primary epithelial cells cannot, but require the coexpression of an immortalizing oncogene, such as the E1A region of adenovirus. We have previously shown that immortalization of primary epithelial cells by E1A 12S requires the expression of five r...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Gopalakrishnan S,Fischer RS,Quinlan MP

    更新日期:1996-12-19 00:00:00

  • Chk1 deficiency in the mouse small intestine results in p53-independent crypt death and subsequent intestinal compensation.

    abstract::Chk1 is a serine/threonine protein kinase that is activated by a wide range of DNA-damaging agents to slow the cell cycle during S phase and G2/M. Abrogation of these cell-cycle checkpoints using Chk1 inhibitors results in hypersensitivity to DNA-damaging agents in vitro and may provide a potential therapeutic tool to...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.482

    authors: Greenow KR,Clarke AR,Jones RH

    更新日期:2009-03-19 00:00:00

  • siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts.

    abstract::The chromosomal translocation t(8;21) is associated with 10-15% of all cases of acute myeloid leukaemia (AML). The resultant fusion protein AML1/MTG8 interferes with haematopoietic gene expression and is an important regulator of leukaemogenesis. We studied the effects of small interfering RNA (siRNA)-mediated AML1/MT...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209638

    authors: Dunne J,Cullmann C,Ritter M,Soria NM,Drescher B,Debernardi S,Skoulakis S,Hartmann O,Krause M,Krauter J,Neubauer A,Young BD,Heidenreich O

    更新日期:2006-10-05 00:00:00

  • Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer.

    abstract::The efficacy of anticancer therapy is limited by the development of drug resistance. While the role of p53 in the intrinsic sensitivity of human cancer cells to paclitaxel (PTX) remains controversial, its role in acquired paclitaxel resistance has never been addressed. In this study we examined the p53 status of three...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203642

    authors: Giannakakou P,Poy G,Zhan Z,Knutsen T,Blagosklonny MV,Fojo T

    更新日期:2000-06-22 00:00:00

  • Impact of G₂ checkpoint defect on centromeric instability.

    abstract::Centromeric instability is characterized by dynamic formation of centromeric breaks, deletions, isochromosomes and translocations, which are commonly observed in cancer. So far, however, the mechanisms of centromeric instability in cancer cells are still poorly understood. In this study, we tested the hypothesis that ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.508

    authors: Deng W,Tsao SW,Mak GW,Tsang CM,Ching YP,Guan XY,Huen MS,Cheung AL

    更新日期:2011-03-17 00:00:00

  • Regulation of SV40 large T-antigen stability by reversible acetylation.

    abstract::Reversible acetylation on protein lysine residues has been shown to regulate the function of both nuclear proteins such as histones and p53 and cytoplasmic proteins such as alpha-tubulin. To identify novel acetylated proteins, we purified several proteins by the affinity to an anti-acetylated-lysine antibody from cell...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209731

    authors: Shimazu T,Komatsu Y,Nakayama KI,Fukazawa H,Horinouchi S,Yoshida M

    更新日期:2006-11-30 00:00:00

  • Lack of CD45 in FLT3-ITD mice results in a myeloproliferative phenotype, cortical porosity, and ectopic bone formation.

    abstract::The receptor tyrosine kinase FLT3 is expressed in myeloid and lymphoid progenitor cells. Activating mutations in FLT3 occur in 25-30% of acute myeloid leukaemia (AML) patients. Most common are internal tandem duplications of sequence (ITD) leading to constitutive FLT3-ITD kinase activity with an altered signalling qua...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0757-y

    authors: Kresinsky A,Schnöder TM,Jacobsen ID,Rauner M,Hofbauer LC,Ast V,König R,Hoffmann B,Svensson CM,Figge MT,Hilger I,Heidel FH,Böhmer FD,Müller JP

    更新日期:2019-06-01 00:00:00

  • The Myb-related protein MYPOP is a novel intrinsic host restriction factor of oncogenic human papillomaviruses.

    abstract::The skin represents a physical and chemical barrier against invading pathogens, which is additionally supported by restriction factors that provide intrinsic cellular immunity. These factors detect viruses to block their replication cycle. Here, we uncover the Myb-related transcription factor, partner of profilin (MYP...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0398-6

    authors: Wüstenhagen E,Boukhallouk F,Negwer I,Rajalingam K,Stubenrauch F,Florin L

    更新日期:2018-11-01 00:00:00

  • Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis.

    abstract::The NAD-dependent deacetylase sirtuin 1 (SIRT1), a member of the mammalian sirtuin family, plays a pivotal role in deacetylating histone and nonhistone proteins. Recently, it has been reported that SIRT1 is upregulated in various kinds of tumors and is associated with cell growth and metastasis. However, the factors a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-1298-0

    authors: Yu L,Dong L,Li H,Liu Z,Luo Z,Duan G,Dai X,Lin Z

    更新日期:2020-05-01 00:00:00

  • The chromosomal translocation t(X;14)(q28;q11) in T-cell pro-lymphocytic leukaemia breaks within one gene and activates another.

    abstract::Chromosomal translocation t(X;14)(q28;q11) has been observed in patients with pro-lymphocytic T-cell leukaemia (T-PLL). In two cases of T-PLL, one of which was associated with Ataxia telangiectasia (AT), the chromosomal break occurred in two different introns of a gene c6.1A, located at the Xq28 locus. Fusion transcri...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Fisch P,Forster A,Sherrington PD,Dyer MJ,Rabbitts TH

    更新日期:1993-12-01 00:00:00

  • Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45.

    abstract::Recently Gadd45, a p53-regulated stress protein, has been implicated in the activation of a G2/M checkpoint after damage by UV radiation and alkylating agents. While inhibitory phosphorylation of Cdc2 and suppression of cyclin B1 levels are known to be involved in G2 delays after genotoxic stress, Gadd45 has now been ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202667

    authors: Zhan Q,Antinore MJ,Wang XW,Carrier F,Smith ML,Harris CC,Fornace AJ Jr

    更新日期:1999-05-06 00:00:00

  • A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma.

    abstract::Bcl-2 or Bcl-X(L) confers resistance to chemotherapy in multiple myeloma (MM). Here we characterized the effects of ABT-737, a potent small-molecule inhibitor of antiapoptotic proteins Bcl-2, Bcl-X(L) and Bcl-w with markedly higher affinity than previously reported compounds, on human MM cells. ABT-737 induces apoptos...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210028

    authors: Chauhan D,Velankar M,Brahmandam M,Hideshima T,Podar K,Richardson P,Schlossman R,Ghobrial I,Raje N,Munshi N,Anderson KC

    更新日期:2007-04-05 00:00:00

  • Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer.

    abstract::Axl is a receptor that induces proliferation, migration and invasion in cancer. In this study, we show that specific microRNAs (miRNAs) target the 3'-UTR of Axl. Luciferase-reporter assays with wild-type and deleted miR-34 and miR-199a/b seed sequences of Axl 3'-UTR confirmed the specificity of targeting. An inverse c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.13

    authors: Mudduluru G,Ceppi P,Kumarswamy R,Scagliotti GV,Papotti M,Allgayer H

    更新日期:2011-06-23 00:00:00

  • Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.

    abstract::The heterogeneous breast cancers can be classified into different subtypes according to their histopathological characteristics and molecular signatures. Foxa1 expression is linked with luminal breast cancer (LBC) with good prognosis, whereas Twist1 expression is associated with basal-like breast cancer (BLBC) with po...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.286

    authors: Xu Y,Qin L,Sun T,Wu H,He T,Yang Z,Mo Q,Liao L,Xu J

    更新日期:2017-02-23 00:00:00

  • New insights into apoptosis signaling by Apo2L/TRAIL.

    abstract::Apoptosis ligand 2 tumor necrosis factor (TNF)-related apoptosis-inducing ligand (Apo2L/TRAIL) belongs to a small subset of proapoptotic protein ligands in the TNF superfamily. This subset, which also includes Fas ligand and TNF-alpha, can activate the extrinsic apoptotic cell death pathway on binding to cognate death...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.221

    authors: Gonzalvez F,Ashkenazi A

    更新日期:2010-08-26 00:00:00

  • Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms.

    abstract::We have evaluated the transcriptional activation of a human p21 promoter reporter construct by transfection of BRCA1 expression constructs into tumorigenic and nontumorigenic human breast cell lines. Two cell lines with wildtype p53 (MCF-7 and MCF10A) demonstrated transcriptional activation of the p21 promoter by full...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204025

    authors: Lu M,Arrick BA

    更新日期:2000-12-14 00:00:00

  • Oncology studies using siRNA libraries: the dawn of RNAi-based genomics.

    abstract::High-throughput, human cell-based applications of RNA-mediated interference (RNAi) have emerged in recent years as perhaps the most powerful of a 'second wave' of functional genomics technologies. The available reagents and methodologies for RNAi screening studies now enable a wide range of different scopes and scales...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1208072

    authors: Sachse C,Echeverri CJ

    更新日期:2004-11-01 00:00:00

  • The human ETS1 gene: genomic structure, promoter characterization and alternative splicing.

    abstract::Genomic clones encompassing the human ETS1 gene were isolated and utilized to define its molecular organization. This gene consists of eight exons spanning over 60 kb. The 5' end of the human ETS1 gene was subcloned and characterized. S1 nuclease, primer extension and RNAase protection analyses of human mRNAs showed m...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Jorcyk CL,Watson DK,Mavrothalassitis GJ,Papas TS

    更新日期:1991-04-01 00:00:00

  • Cholecystokinin-2 receptor modulates cell adhesion through beta 1-integrin in human pancreatic cancer cells.

    abstract::Several lines of evidence suggest that gastrin and the CCK-2 receptor (CCK2R) could contribute to pancreatic carcinogenesis by modulating processes such as proliferation, cell adhesion or migration. In the current study, we used a 'cancer gene array' and identified beta1-integrin subunit as a new gastrin-regulated gen...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209484

    authors: Cayrol C,Clerc P,Bertrand C,Gigoux V,Portolan G,Fourmy D,Dufresne M,Seva C

    更新日期:2006-07-27 00:00:00

  • Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.

    abstract::Arg and c-Abl represent the mammalian member of the Abelson family of nonreceptor protein tyrosine kinases. The two proteins are composed of SH2, SH3, kinase and C-terminal domains. To examine Arg structure-function relationships we analysed a Gag-Arg fusion protein, analogous to the oncogenic Gag-Abl fusion protein o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Mysliwiec T,Perego R,Kruh GD

    更新日期:1996-02-01 00:00:00

  • Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals.

    abstract::Early studies demonstrated that male melanoma patients have worse survival than female patients, yet the detailed mechanisms for this gender difference remain unclear. We analyzed around 100 cases of human melanoma and found that androgen receptor (AR) positive melanoma patients have worse survival outcomes compared w...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.330

    authors: Wang Y,Ou Z,Sun Y,Yeh S,Wang X,Long J,Chang C

    更新日期:2017-03-23 00:00:00

  • HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer.

    abstract::Hepatitis B virus (HBV) infection is a major risk factor worldwide for the development of hepatocellular carcinoma (HCC). Integrated HBV DNA fragments, often highly rearranged, are frequently detected in HCC. In woodchuck, the viral enhancer plays a central role in hepatocarcinogenesis, but in humans the mechanism of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204879

    authors: Shamay M,Agami R,Shaul Y

    更新日期:2001-10-18 00:00:00

  • The p53/p73 - p21CIP1 tumor suppressor axis guards against chromosomal instability by restraining CDK1 in human cancer cells.

    abstract::Whole chromosome instability (W-CIN) is a hallmark of human cancer and contributes to the evolvement of aneuploidy. W-CIN can be induced by abnormally increased microtubule plus end assembly rates during mitosis leading to the generation of lagging chromosomes during anaphase as a major form of mitotic errors in human...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01524-4

    authors: Schmidt AK,Pudelko K,Boekenkamp JE,Berger K,Kschischo M,Bastians H

    更新日期:2021-01-01 00:00:00

  • A retroviral library genetic screen identifies IRF-2 as an inhibitor of N-ras-induced growth suppression in leukemic cells.

    abstract::Activating mutations of the N-ras gene occur at relatively high frequency in acute myeloid leukemia and myelodysplastic syndrome. Somewhat paradoxically, ectopic expression of activated N-ras in primary hematopoietic cells and myeloid cell lines (in some cases) can lead to inhibition of proliferation. Expression of mu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208877

    authors: Passioura T,Shen S,Symonds G,Dolnikov A

    更新日期:2005-11-10 00:00:00

  • A novel pro-apoptotic function of RACK1: suppression of Src activity in the intrinsic and Akt pathways.

    abstract::Earlier we showed that RACK1 regulates growth of human colon cells by suppressing Src activity at G(1) and mitotic checkpoints. Here, we show that RACK1 also induces apoptosis of the cells, partly by inhibiting Src. In the intrinsic pathway, RACK1 inhibits expression of anti-apoptotic Bcl-2 and Bcl-X(L), induces expre...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.293

    authors: Mamidipudi V,Cartwright CA

    更新日期:2009-12-17 00:00:00